Previous Close | 0.1350 |
Open | 0.1350 |
Bid | 0.1350 x N/A |
Ask | 0.1900 x N/A |
Day's Range | 0.1350 - 0.1350 |
52 Week Range | 0.1350 - 1.2500 |
Volume | |
Avg. Volume | 9,246 |
Market Cap | 2.137M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Pluribus Technologies Corp. (TSXV: PLRB) ("Pluribus" or the "Company") is pleased to announce the closing of the sale (the "Transaction") of substantially all of the assets, tangible and intangible, of its wholly-owned subsidiary, TeleMED Diagnostic Management Inc., ("TeleMED") and all of the issued and outstanding fully-diluted shares of its wholly-owned subsidiary, TDM Telehealth Technology Ltd. ("TDM") for an aggregate purchase price of $5,070,000, payable in cash (the "Purchase Price") pursu
Pluribus Technologies Corp. (TSXV: PLRB) ("Pluribus" or the "Company"), an acquiror of small, profitable technology companies, today announced its financial results for the fourth quarter ended December 31, 2023. The Company's consolidated financial statements and accompanying notes for the quarters ended December 31, 2023 and 2022 are available under Pluribus' profile on SEDAR (www.sedarplus.com). All dollar amounts are in thousands of Canadian dollars unless otherwise noted. Certain metrics, i
Pluribus Technologies Corp. (TSXV: PLRB) ("Pluribus" or the "Company"), a growing acquirer of small, profitable technology companies, today announced that Company management will host a conference call to discuss its fiscal 2024 fourth quarter financial results on Tuesday April 30, 2024. Pluribus intends to release its financial results following the close of markets on Monday April 29, 2024.